{"personrec":{"StatusID":1,"PersStatus":null,"Status":"Valid","PersID":36356,"PersName":"Van Oosterom, Allan","PublicFlag":1,"CheckedFlag":0,"Surname":"Van Oosterom","Firstname":"Allan","Initials":"A.T.","AddressedAs":null,"Function":null,"DateLastModified":{"date":"2023-05-02 10:08:18.393000","timezone_type":1,"timezone":"+00:00"},"PersTitle":null,"PersStatusID":null,"AbstractEnglish":null,"AbstractOtherLang":null,"AbstractLangCode":null,"AbstractLangID":null,"AutID":344450,"ND":null,"UD":null},"loaninfo":null,"pictures":[],"institutes":null,"pastins":[],"projects":[],"datasets":null,"references":{"A1":[{"BRefID":301320,"RR":"<b>Schöffski, P.; Dumez, H.; Wolter, P.; Stefan, C.; Wozniak, A.; Jimeno, J.; Van Oosterom, A.T.</b> (2008). Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma. <i>Expert Opinion on Pharmacotherapy 9(9)</i>: 1609-1618. <a href=\"https://dx.doi.org/10.1517/14656566.9.9.1609\" target=\"_blank\">https://dx.doi.org/10.1517/14656566.9.9.1609</a>","AutID":344450,"MonDate":null,"AnaDate":2008,"PeerRev":1,"outputType":"1_A1","OpenAcc":0},{"BRefID":338237,"RR":"<b>Sparidans, R.W.; Rosing, H.; Hillebrand, M.J.X.; López-Lázaro, L.; Jimeno, J.M.; Manzanares, I.; van Kesteren, C.; Cvitkovic, E.; van Oosterom, A.T.; Schellens, J.H.M.; Beijnen, J.H.</b> (2001). Search for metabolites of ecteinascidin 743, a novel, marine-derived, anti-cancer agent, in man. <i>Anti-Cancer Drugs 12(8)</i>: 653-666. <a href=\"https://hdl.handle.net/10.1097/00001813-200109000-00003\" target=\"_blank\">https://hdl.handle.net/10.1097/00001813-200109000-00003</a>","AutID":454160,"MonDate":null,"AnaDate":2001,"PeerRev":1,"outputType":"1_A1","OpenAcc":0}]},"urls":null,"spcols":null,"thesterms":null,"taxterms":null,"pub":1,"newses":null,"updses":null,"urlmaps":[],"resmessage":"no id specified","complete":1}